Trial Profile
LY2216684 and Fluoxetine Pharmacokinetic Interaction Study in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Fluoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company (India) Pvt. Ltd
- 20 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2010 New trial record